XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net income $ 458 $ 1,820
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 698 650
Amortization of debt-related costs 7 4
Share-based compensation 29 24
Inventory valuation charges 323  
Equity investments -    
Equity income (61) (128)
Distributions of earnings, net of tax 81 149
Deferred income taxes (90) 110
Changes in assets and liabilities that provided (used) cash:    
Accounts receivable 487 (263)
Inventories 463 (173)
Accounts payable (485) (102)
Other, net (76) (248)
Net cash provided by operating activities 1,834 1,843
Cash flows from investing activities:    
Expenditures for property, plant and equipment (1,248) (1,221)
Purchases of available-for-sale debt securities (270)  
Proceeds from sales and maturities of available-for-sale debt securities 0 511
Purchases of equity securities (184)  
Proceeds from sales of equity securities 1 332
Other, net (26) (78)
Net cash used in investing activities (1,727) (456)
Cash flows from financing activities:    
Repurchases of Company ordinary shares (4) (512)
Dividends paid - common stock (701) (760)
Purchase of non-controlling interest (30) (63)
Issuance of long-term debt 2,492  
Repayments of long-term debt (500) (1,000)
Payments of debt issuance costs (18) (4)
Issuance of short-term debt 521 2,000
Repayments of short-term Debt (500)  
Net proceeds from (repayments of) commercial paper 212 (128)
Payments on forward-starting interest rate swaps that include financing elements (238)  
Proceeds from settlement of cash flow hedges 346  
Other, net (12) (15)
Net cash provided by (used in) financing activities 1,568 (482)
Effect of exchange rate changes on cash 15 2
Increase in cash and cash equivalents and restricted cash 1,690 907
Cash and cash equivalents and restricted cash at beginning of period 888 401
Cash and cash equivalents and restricted cash at end of period $ 2,578 $ 1,308